DRMAW - Dermata Therapeutics Inc - Warrants (13/08/2026)
Previous close
0.0093
0 0%
Share volume: 15,384
Last Updated: Thu 29 Aug 2024 06:00:00 AM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$0.01
0.00
0.00%
Fundamental analysis
4%
Profitability
0%
Dept financing
0%
Liquidity
0%
Performance
10%
Performance
5 Days
-45.91%
1 Month
-35.82%
3 Months
6.17%
6 Months
-45.22%
1 Year
-63.40%
2 Year
-91.40%
Key data
Stock price
$0.01
DAY RANGE
N/A - N/A
52 WEEK RANGE
$0.01 - $0.03
52 WEEK CHANGE
-$0.52
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
Company detail
CEO:
Region: US
Website:
Employees: 6
IPO year: -
Issue type:
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website:
Employees: 6
IPO year: -
Issue type:
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
dermata therapeutics, llc is a research company based out of 12340 el camino real, san diego, california, united states.
Recent news